Dr. Wang Lixia and Dr. Yogan Pillay receive KNCV award

Dr. Wang Lixia and Dr. Yogan Pillay have been awarded with the prestigious KNCV Tuberculosis Foundation Award for Eminence in Tuberculosis Control. KNCV executive director Kitty van Weezenbeek presented the Dr. Karel Styblo medallion and a certificate of appreciation to Dr. Wang and Dr. Pillay at the closing ceremony of the 49th Union World Conference on Lung Health in The Hague.

Dr. Wang Lixia is the former NTP Director of China and Dr. Yogan Pillay is the Deputy Director-General at South Africa’s National Department of Health. ”Both of them spent their careers in the public service fighting TB”, said Kitty van Weezenbeek at the ceremony. ”They brought innovations and remained working in public health services, both in countries that have a major burden of TB.”

KNCV presents this prestigious award every five years to honor those who have provided a long-term and significant contribution to the fight against tuberculosis.

For Dr. Wang Lixia, the Award Committee acknowledged her longstanding leadership in infectious disease control. She served TB control in her country for more than 15 years. Her strong drive has been an inspiration for many, both national and international, and has led to the introduction of various innovations, including the introduction of electronic recording and reporting; MDR-TB treatment programs; molecular diagnostics and active case-finding in China. In addition to Dr. Wangs national achievements, she greatly contributed to international policy development through WHO, most notably as a member of the prestigious WHO Strategic Technical Advisory Committee. KNCV is thankful to look back on a close and excellent collaboration.

For Dr. Yogan Pillay the Award Committee acknowledged his longstanding leadership in infectious diseases control at the primary health care level. Dr. Pillay also served TB elimination efforts in his country for more than 15 years. His vision to tackle head-on the dual epidemics of HIV and TB by bringing together programs, services and research, is an inspiration for many, both national and international. You and your government have transformed South Africa into an eager and early adopter of innovations, both in the field of TB diagnostics and by bringing the best drugs available to the fight against all forms of the disease. In addition to his national achievements, Dr. Pillay greatly contributed to international policy development through WHO, most notably as a member of the WHO Strategic Technical Advisory Group for HIV.

The closing ceremony marked the end of the 49th Union World Conference in The Hague. KNCV was the local host of the conference, which was attended by over 3500 researchers, global advocates scientists and healthcare professionals from more than 125 countries world-wide.

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.